Dual affinity nanoparticles for the treatment of cancer
AssigneeVanderbilt University
InventorsMichael R. KING, Maria LOPEZ CAVESTANY, Zhenjiang ZHANG
Life of this patent
Estimating the term…
Loading patent…
AssigneeVanderbilt University
InventorsMichael R. KING, Maria LOPEZ CAVESTANY, Zhenjiang ZHANG
Estimating the term…
The present disclosure described bi-functional delivery particles with the ability to bind to two different cell types in a distinct fashion. Employing a first ligand with differential binding capabilities, the delivery particles may bind to a first target, such as cell, in a reversible fashion such that when they encounter a second target (e.g., cell) a second ligand that bind irreversibly to the second target will disrupt the binding to the first target. As such, the first target acts as a carrier to delivery the particle to a diagnostic or therapeutic second target. In particular aspects, the first and second cells are circulating cells.
A delivery particle comprising:
A delivery particle comprising:
18-19. (canceled)
22-29. (canceled)
A delivery particle comprising:
Dependencies are inferred from the claim text.